Skip to content
OpenCapital
Get started

Harmony Biosciences Holdings, Inc. HRMY Net debt

Discontinued — last reported Q1 '26

Net debt at other companies

Cabot Corporation logo
Cabot CorporationCBT
1.1×-0.3×
Travel + Leisure logo
Travel + LeisureTNL
6×+1.6×
Unifirst logo
UnifirstUNF
-0.2×-0.1×
HES
Hess MidstreamHESM
3.1×-0.1×
Andersons Inc. logo
Andersons Inc.ANDE
4×+2.1×
Seadrill logo
SeadrillSDRL
1×+0.6×

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.98B-14.9%
Enterprise value$1.55B-24.9%
P/E13.6×-1.6×
P/S2.2×-0.9×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Calculated from Harmony Biosciences Holdings, Inc.’s reported figures.

$164.6Mtotal debt−$589.4Mcash and equivalents=-$424.79M

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s net debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s net debt?
Harmony Biosciences Holdings, Inc. (HRMY) reported net debt of -$424.79M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s net debt changed year-over-year?
Harmony Biosciences Holdings, Inc.'s net debt decreased by 36.4% year-over-year, from -$311.53M to -$424.79M.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s net debt?
Over 5 years (2020 to 2025), Harmony Biosciences Holdings, Inc.'s net debt has grown at a 76.2% compound annual growth rate (CAGR), from -$34.38M to -$583.25M.
What does net debt mean?
Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.